Apple's second-generation Vision Pro headset launches with improved battery life, lighter design, and revolutionary eye-tracking capabilities that make virtual meetings feel more natural than ever before.

DeepMind's AlphaFold 3 identifies optimal drug combinations for individual cancer patients based on their genetic profile, leading to 80% higher remission rates in clinical trials.